436
Participants
Start Date
December 31, 2012
Primary Completion Date
July 31, 2022
Study Completion Date
July 31, 2022
Vitamin D
"* prospective interventional randomized double blind placebo controlled trail~* clinical setting (tertiary university hospital)~* investigator driven, no pharmaceutical sponsor~* cutaneous malignant melanoma patients~* add- on study (placebo or vitamin D) on top of optimal standard care~* 1:1 inclusion ratio (placebo:Vitamin D)~* randomisation after informed consent and screening"
Placebo: Oil
Universitair Ziekenhuis Antwerpen, Dermatology, Edegem
UZLeuven Gasthuisberg, Leuven
Chef de Service du Service Universitaire de Dermatologie, Liège
Dep. of Dermatology, Medical and Health Science Center University of Debrecen, Debrecen
KU Leuven
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER